Plasmacytoma with aberrant expression of myeloid markers, T-cell markers, and cytokeratin.

J S Shin, G A Stopyra, M J Warhol, H A Multhaupt

13 Citations (Scopus)

Abstract

Plasmacytomas are localized neoplastic proliferations of monoclonal plasma cells. When multifocal, the process is referred to as multiple myeloma. These lesions exhibit a pattern of antigen expression and cytomorphology that usually leads to a ready diagnosis. However, potentially troublesome variations in immunophenotype occur. We describe a case of a plasmacytoma from a patient who presented with sudden onset of pain and a lytic lesion of the left proximal humerus. Hematoxylin and eosin-stained sections showed a lymphoproliferative lesion composed of large lymphoid cells, some with plasmacytoid and immunoblastic features. The lesion also showed significant mitotic activity. Immunohistochemical staining was positive for CD45 (LCA), CD56 (N-CAM), CD43 (MT1), and cytokeratin CAM5.2. There was also clonal staining for lambda light chains. In addition, flow cytometric analysis showed positivity for myeloid markers such as CD13, CD33, CD38, and CD138. Significant negative markers include CD20 (L26), CD45RO (UCHL-1), and CD79alpha. The unusual phenotypic features of this plasmacytoma illustrate potential diagnostic pitfalls. It is important to fully study such lesions to correctly classify them, because this has significant impact on prognosis and management.
Original languageEnglish
JournalJournal of Histochemistry and Cytochemistry
Volume49
Issue number6
Pages (from-to)791-2
Number of pages1
ISSN0022-1554
Publication statusPublished - 2001

Fingerprint

Dive into the research topics of 'Plasmacytoma with aberrant expression of myeloid markers, T-cell markers, and cytokeratin.'. Together they form a unique fingerprint.

Cite this